UEMS Medical Specialty

Psychiatry & Neurodevelopment — Page 2

Formulation science addressing mental health: catecholaminergic modulation, ADHD, mood disorders, neuropsychological function, and the gut–brain axis as a therapeutic target.

25

dossiers

Precision Microbiome & Gut-Brain Axis

Gut-Brain Axis in ADHD: Microbiota-Mediated Dopaminergic Pathway Modulation

Developing scientifically validated microbiome-targeted interventions for ADHD involves addressing the challenges of heterogeneity in clinical outcomes and identifying precise microbial mechanisms. Formulating stable, effective probiotics or synbiotics with demonstrated clinical benefits remains a major hurdle.

NeuroinflammationAttention Deficit Disorder with HyperactivityDopamineSerotonin

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.

Discuss a Partnership →← Return to Clinical Matrix

RELATED RESOURCES

R&D Hub — All Scientific CategoriesFull library of evidence-based research covering formulation, bioavailability and clinical nutrition.EXPLORE ›Advanced Formulation Technology PlatformLiposomal, enteric and micellar encapsulation systems with AI-verified safety screening.EXPLORE ›Production Formats & MOQ ReferenceHard capsules 150K, softgels 300K, sachets 250K — connect the science to actual industrial thresholds.EXPLORE ›Physician Supplement Brand Contract ManufacturingClinician-led programmes with zero conflict of interest and full IP ownership.EXPLORE ›Paid Discovery: R&D Due Diligence EntryTransform research findings into a scoped, confidential manufacturing brief.EXPLORE ›Commercialization Intelligence HubRegulatory and market strategy intelligence for supplement brand decision-makers.EXPLORE ›